OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $16,000 | -93.8% | 28,595 | -80.9% | 0.00% | -100.0% |
| Q4 2015 | $258,000 | -25.4% | 149,520 | -8.9% | 0.00% | 0.0% |
| Q3 2015 | $346,000 | -59.7% | 164,127 | -5.3% | 0.00% | -50.0% |
| Q2 2015 | $858,000 | -33.5% | 173,346 | +5.1% | 0.00% | -33.3% |
| Q1 2015 | $1,291,000 | +67.0% | 164,923 | +29.3% | 0.00% | +50.0% |
| Q4 2014 | $773,000 | -59.4% | 127,571 | -71.5% | 0.00% | -60.0% |
| Q3 2014 | $1,905,000 | -19.6% | 447,268 | +16.7% | 0.01% | -16.7% |
| Q2 2014 | $2,368,000 | -8.7% | 383,188 | -4.0% | 0.01% | -14.3% |
| Q1 2014 | $2,595,000 | +42.3% | 399,213 | +28.1% | 0.01% | -12.5% |
| Q2 2013 | $1,823,000 | – | 311,662 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |